|
Market Closed -
Bombay S.E.
06:02:27 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 561.90 INR | +2.42% |
|
+2.86% | +28.14% |
| 08-14 | Coral Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 05-30 | Coral Laboratories Limited Recommends Final Dividend for the Financial Year 2025-2026 | CI |
Company Valuation: Coral Laboratories Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,151 | 912.1 | 817.8 | 1,327 | 2,506 | 1,324 |
| Change | - | -20.78% | -10.34% | 62.25% | 88.85% | -47.17% |
| Enterprise Value (EV) 1 | 1,191 | 729.8 | 517.7 | 1,049 | 2,232 | 1,060 |
| Change | - | -38.7% | -29.07% | 102.64% | 112.77% | -52.5% |
| P/E | 8.49x | 10.1x | 12.7x | 8.4x | 10.4x | 8.08x |
| PBR | 0.84x | 0.58x | 0.53x | 0.75x | 1.25x | 0.63x |
| PEG | - | -0.3x | -0.4x | 0x | 0.2x | -0.3x |
| Capitalization / Revenue | 1.19x | 1.21x | 1.05x | 1.59x | 2.18x | 1.54x |
| EV / Revenue | 1.23x | 0.97x | 0.66x | 1.25x | 1.94x | 1.23x |
| EV / EBITDA | 7.33x | 8.51x | 12.2x | 6.33x | 8.39x | 6.8x |
| EV / EBIT | 8.34x | 11.1x | 25x | 7.18x | 9.07x | 7.88x |
| EV / FCF | -62.2x | -107x | 7.71x | -11.2x | -25.8x | -8.71x |
| FCF Yield | -1.61% | -0.93% | 13% | -8.94% | -3.88% | -11.5% |
| Dividend per Share 2 | - | - | - | 2 | 1.5 | 2 |
| Rate of return | - | - | - | 0.54% | 0.21% | 0.54% |
| EPS 2 | 37.94 | 25.32 | 18.04 | 44.19 | 67.61 | 45.85 |
| Distribution rate | - | - | - | 4.53% | 2.22% | 4.36% |
| Net sales 1 | 965.7 | 756.1 | 781.2 | 836.6 | 1,150 | 859 |
| EBITDA 1 | 162.5 | 85.74 | 42.45 | 165.8 | 265.9 | 155.9 |
| EBIT 1 | 142.8 | 65.97 | 20.73 | 146.1 | 246 | 134.6 |
| Net income 1 | 135.5 | 90.46 | 64.45 | 157.9 | 241.6 | 163.8 |
| Net Debt 1 | 39.3 | -182.3 | -300.1 | -277.9 | -273.9 | -263.7 |
| Reference price 2 | 322.25 | 255.30 | 228.90 | 371.40 | 701.40 | 370.55 |
| Nbr of stocks (in thousands) | 3,573 | 3,573 | 3,573 | 3,573 | 3,573 | 3,573 |
| Announcement Date | 9/1/21 | 9/6/22 | 7/18/23 | 9/5/24 | 9/3/25 | 9/4/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 20.39M | |
| 32.45x | 11.78x | 23.93x | 0.61% | 1,019B | |
| 28.48x | 6.32x | 17.74x | 2.09% | 617B | |
| 33.26x | 7.78x | 16.08x | 2.64% | 464B | |
| 104.98x | 5.87x | 24.89x | 2.36% | 356B | |
| 18.81x | 4.58x | 11.36x | 2.9% | 333B | |
| 19.83x | 5.17x | 12.78x | 3.09% | 267B | |
| 20.02x | 4.17x | 11.86x | 2.13% | 244B | |
| 25.46x | 6.66x | 11.86x | 2.5% | 218B | |
| -43.78x | 6.39x | 24.97x | 2.27% | 179B | |
| Average | 26.61x | 6.52x | 17.28x | 2.29% | 369.72B | |
| Weighted average by Cap. | 31.80x | 7.61x | 18.61x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 524506 Stock
- Valuation Coral Laboratories Limited
Select your edition
All financial news and data tailored to specific country editions
